![Carolina Trkulja](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carolina Trkulja
Chief Executive Officer at
FLUICELL AB
Profile
Carolina Trkulja is the founder of Oblique Therapeutics AB. Dr. Trkulja is currently the Chief Executive Officer at Fluicell AB since 2023.
Dr. Trkulja holds a doctorate degree from Chalmers University of Technology.
Carolina Trkulja active positions
| Companies | Position | Start |
|---|---|---|
| FLUICELL AB | Chief Executive Officer | 2022-12-31 |
Former positions of Carolina Trkulja
| Companies | Position | End |
|---|---|---|
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Founder | - |
Training of Carolina Trkulja
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluicell AB
 Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
- Stock Market
- Insiders
- Carolina Trkulja
